SLEEP 2025
Explore cutting-edge science and clinical insights from SLEEP 2025—the leading international meeting for sleep medicine and research professionals—happening June 7–11 in Seattle, WA.
There are both positives and negatives associated with either testing method.
The researchers focused on white matter microstructures in the relationship between REM-OSA and cognition decline.
Most patients switching from modafinils to solriamfetol preferred it, citing better effects; others reverted due to side effe
The drug was well-tolerated and adverse reactions were minimal to moderate in severity.
The researchers considered age, sex, and race/ethnicity to determine differing pathophysiologies.
Advertisement
Advertisement